Assessing the Clinical Performance of a Presymptomatic Acute Graft-Versus-Host Disease Biomarker Test in Hematopoietic Stem Cell Transplant Recipients
The aGVHD presymptomatic algorithm was suboptimal for routine clinical use. Further development of predictive aGVHD biomarkers may be required to aid in the management of allogeneic HCT recipients.
Authors
- James L. Zehnder (ORCID: https://orcid.org/0000-0002-5380-303X)
- Benjamin A. Pinsky (ORCID: https://orcid.org/0000-0001-8751-4810)
- Everett Meyer (ORCID: https://orcid.org/0000-0001-7953-853X)
- Ariadna García
- Rafael C Pulgrossi
- Lin Wang
Institutions
- Stanford Blood Center (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- The Journal of Applied Laboratory Medicine
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1093/jalm/jfaf193
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00